Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

With weight loss drugs taking the world by storm, more people are exploring adding these medical marvels to their toolkits.

Discontinuing obesity medicines often means the weight comes back and people lose the cardiovascular and metabolic benefits ...

Oprah Winfrey says she had one big main side effect from taking a GLP-1 weight-loss drug. The most common problems for ...

There’s no sign of GLP-1s slowing down anytime soon, especially now that they have the support of top-notch athletes.

GLP-1 weight-loss pills appear to be just as effective as injections, with clinical trials showing similar average weight ...

The GLP-1 moment signals how quickly a high-demand therapy can upend established care patterns—and how similar innovations ...

Microdosing GLP-1 weight loss drugs like semaglutide is trendy, with supporters touting benefits such as lower costs and potentially fewer side effects. But some doctors are skeptical, calling it ...

Friendly" labels on the packaging are becoming more common as a growing number of Americans try obesity drugs like Wegovy and ...

The sustainability of weight-loss drugs is under scrutiny as new research shows that people who stop taking glucagon-like ...

When endocrinologist Dan Bessesen, MD, looked online and saw how easy it would be for him to purchase a weight loss drug from ...

New fleet of weight loss drugs are more effective than the current popular obesity medications at trial - One in eight ...